ENTITY
GSK

GSK (GSK LN)

143
Analysis
Health Care • United Kingdom
GSK is a British multinational biopharmaceutical company focused on the research, development, and delivery of innovative vaccines and specialty medicines. It addresses major disease areas including HIV, respiratory, oncology, and infectious diseases. The company was established in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, and is headquartered in London, England.
more
bullish•Kingsoft Cloud
•10 May 2020 13:33

ECM Weekly (10 May 2020) - Kingsoft Cloud, NetEase, Central China New Life, Peijia Medical, Kintor,

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. As...

Share
bullish•Hindustan Unilever
•06 May 2020 20:17

Hindustan Unilever Placement - As Expected, Doing It Right

In my insight earlier this week, Hindustan Unilever Prospective Placement - Early Look - The US$3.6bn Overhang, I wrote about how GlaxoSmithKline...

Logo
651 Views
Share
bearish•Hindustan Unilever
•05 May 2020 16:36

Hindustan Unilever Prospective Placement - Early Look - The US$3.6bn Overhang

GlaxoSmithKline PLC (GSK LN) owns about 5.7% of Hindustan Unilever (HUVR IN), through shares that it recently received upon the completion of...

Logo
611 Views
Share
•28 Feb 2019 04:23

Amarin Q4 2018 Conference Call--Strong Sales & High Confidence

Q4 2018 Revenues Stronger Than Pre-Announcement on January 4th: Amarin released its Q4 2018 results today and held a conference call. Results of...

Logo
856 Views
Share
•07 Jan 2019 11:15

Amarin--2019's Biggest Buyout Target for Big Pharma

Amarin (AMRN US), a US-listed biotech firm,Ā presented the fullĀ results of its "Reduce-It" (RI) clinical trial at a conference for the American...

Logo
4.9k Views
Share
x